Rob Quail 
The Ethics of Genetic Commerce [PDF ebook] 

Our rapidly expanding genetic knowledge today points toward a near
future in which the elements of humanity closest to our moral core
may themselves be produced, manipulated, commodified, and
exchanged.

* * Explores the moral and ethical concerns derived from an
increasing knowledge of genetics and the variety of its commercial
applications

* A major contribution to the emerging understanding of the role
that ethics will play in genetic commerce

* Written by experts from the academic and corporate sector, with
diverse backgrounds in business, social science, and
philosophy

* Addresses a range of relevant issues, including genetic
screening, the use of individual’s genetic information, the
rise of genetically modified foods, patenting, pharmaceutical
mergers and monopolization, and the implications of genetic testing
on non-human mammals

Table of Content

Preface.

Part I: Genetic Screening.

1. Is a Genetics Screening Program for Job Applicants Ethical?
An Analysis of the Conditions Necessary for Required Genetic
Screenings in the Hiring Process (Thomas Harter).

2. The Business of Genetic Screening (Duane Windsor).

3. Genetic Commerce: The Challenges for Human Resource
Management (Karen S. Markel and Lizabeth A. Barclay).

4. Geneticize Me! The Case for Direct-to-Consumer Genetic
Testing (Ronald Munson).

5. Proscription, Prescription, or Market Process? Comments on
Genetic Screening (Eugene Heath).

Part II: Genetically Modified Foods.

6. Transgenic Organisms, the European Union, and the World Trade
Organization(Dennis Cooley).

7. Commercialization of the Agrarian Ideal and Arguments against
the New ‘Green Revolution: Feeding the World with
‘Frankenfoods’? (Johann A. Klaasen).

8. Corporate Decisions about GM Food Labeling (Chris
Mac Donald and Melissa Whellams).

9. Moral Imagination, Stakeholder Engagement, and Genetically
Modified Organisms (Denis Arnold).

Part III: Corporate Governance and Genetic Commerce.

10. Who Owns My Ideas About Your Body? (Asher Meir).

11. Pharmaceutical Mergers and Genetic Technology: A Problematic
Combination (Michael Potts).

12. Stakeholder Care Theory: The Case of Genetic Engineering
(Jamie R. Hendry).

13. Unresolved Issues and Further Questions: Meir, Potts and
Hendry (Laura Hartman)

About the author

Robert W. Kolb holds the Frank W. Considine Chair in Applied Ethics at Loyola University Chicago. He was formerly Assistant Dean for Business and Society (2003-2006) at the University of Colorado, and John S. and James L. Knight Professor of Finance at the University of Miami. He is author and co-author of numerous texts in finance, including Futures, Options, and Swaps, 5e (with James A. Overdahl, Blackwell, 2007) and Understanding Futures Markets, 6e (with James A. Overdahl, Blackwell, 2006).